Accès ouvert
2026
article
OpenAlex
Rodney J. Ellis, Stephanie L. Pugh, James B. Yu, Felix Y. Feng et autres
Importance: The treatment of prostate cancer with radiotherapy is evolving. How quickly radiotherapy can be delivered, and the relative risks and benefits of such a treatment, is of significant public interest. Objective: To determine whether stereotactic body radiotherapy (SBRT) was superior to …
us, ca, ie
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Mutlay Sayan, Huei-Chung Huang, Erin L. Stewart, Timothy N. Showalter et autres
Background/Objectives: This study explored whether a multimodal artificial intelligence (MMAI) model integrating digitized histopathology and clinical features can identify prostate cancer patients who may benefit from neoadjuvant hormonal therapy (NHT) and whole-pelvic radiotherapy (WPRT). Methods: This secondary analysis of NRG/RTOG 9413 included …
us, gb
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Joanne Barnes Weidhaas, J. Harris, Maura L. Gillison, Dukagjin M. Blakaj et autres
PURPOSE: NRG/RTOG 1016 was a phase III noninferiority trial comparing IMRT + cisplatin versus IMRT + cetuximab for human papillomavirus-positive oropharyngeal squamous cell cancer (HPV+ OPSCC). A germline mutation (the KRAS-variant) previously identified patients with improved outcomes to radiation + cetuximab + …
us, ca
(code pays fourni par la source)